Literature DB >> 25712953

Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy.

Eve A Roberts1, Matthew Herder2, Aidan Hollis2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25712953      PMCID： PMC4387034          DOI： 10.1503/cmaj.140308

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

1.  Incentives for drug development--the curious case of colchicine.

Authors:  Aaron S Kesselheim; Daniel H Solomon
Journal:  N Engl J Med       Date:  2010-04-14       Impact factor: 91.245

2.  When everyone is an orphan: against adopting a U.S.-styled orphan drug policy in Canada.

Authors:  Matthew Herder
Journal:  Account Res       Date:  2013       Impact factor: 2.622

3.  Pricing for orphan drugs: will the market bear what society cannot?

Authors:  Brian P O'Sullivan; David M Orenstein; Carlos E Milla
Journal:  JAMA       Date:  2013-10-02       Impact factor: 56.272

4.  Diagnosis and treatment of Wilson disease: an update.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

5.  The trientine crisis in Canada: a call to advocacy.

Authors:  Natasha Chandok; Eve A Roberts
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04

6.  Diagnosis and management of Wilson's disease: results of a single center experience.

Authors:  Valentina Medici; Carlo Pietro Trevisan; Renata D'Incà; Michela Barollo; Lucia Zancan; Stefano Fagiuoli; Diego Martines; Paola Irato; Giacomo Carlo Sturniolo
Journal:  J Clin Gastroenterol       Date:  2006 Nov-Dec       Impact factor: 3.062

7.  Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.

Authors:  J M Walshe
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

8.  Research into rare diseases of childhood.

Authors:  Mark L Batshaw; Stephen C Groft; Jeffrey P Krischer
Journal:  JAMA       Date:  2014-05-07       Impact factor: 56.272

9.  Incentives for orphan drug research and development in the United States.

Authors:  Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Sheryl L Szeinbach; Jay Visaria
Journal:  Orphanet J Rare Dis       Date:  2008-12-16       Impact factor: 4.123

10.  Funding innovation for treatment for rare diseases: adopting a cost-based yardstick approach.

Authors:  Garret Kent Fellows; Aidan Hollis
Journal:  Orphanet J Rare Dis       Date:  2013-11-16       Impact factor: 4.123
View more
  1 in total

Review 1.  Update on the Diagnosis and Management of Wilson Disease.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2018-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.